PRAMEF19: A Cancer/Testis Antigen with Potential Roles in Tumor Immunity and Germline Development

Explore the genomic context, expression profile, and clinical significance of PRAMEF19, a member of the PRAME family implicated in cancer and reproductive biology.

Gene Information Card

Symbol PRAMEF19
Full Name PRAME family member 19
Gene Type protein coding
Chromosomal Location 1p36.21
NCBI Gene ID 401429 ncbi.nlm.nih.gov/gene/401429
Ensembl ID ENSG00000215261
UniProt ID P0C7P0
OMIM ID 615555
HGNC ID 30664
Aliases PRAME family member 19, PRAME-like protein

Description

PRAMEF19 (PRAME family member 19) is a protein-coding gene located on chromosome 1p36.21. It belongs to the PRAME (Preferentially expressed Antigen in Melanoma) family, which encodes cancer/testis antigens. These proteins are normally expressed in testis and placenta but are often aberrantly expressed in various cancers, where they may play roles in tumor immunity and proliferation. PRAMEF19 is part of a cluster of PRAME family members on chromosome 1, and its specific function is not fully characterized, but it is predicted to be involved in transcriptional regulation and may serve as a target for cancer immunotherapy.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Cancer (general) As a cancer/testis antigen, PRAMEF19 may be aberrantly expressed in tumors, potentially eliciting an immune response or contributing to oncogenesis. Inferred from family member PRAME; direct evidence limited.
Male infertility Expression in testis suggests a role in spermatogenesis; dysregulation may affect fertility. Inferred from expression pattern; no direct clinical evidence.

Expression Profile

Tissue Expression
Tissue nTPM level
Testis Not available Expected high expression (cancer/testis antigen)
Placenta Not available Expected moderate expression
Other tissues Not available Low or no expression in normal tissues
Cell Line Expression
Cell Line nTPM Notes
Cancer cell lines (e.g., melanoma) Not available Potential expression in cancer cell lines, but data not curated in GTEx or Human Protein Atlas for this gene.
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
No specific variants curated Not applicable Not available No disease-associated variants reported in ClinVar or COSMIC for PRAMEF19.
Mutation functional classification

Loss of Function (LOF)

No evidence of loss-of-function mutations in PRAMEF19; functional impact unknown.

Gain of Function (GOF)

No evidence of gain-of-function mutations; potential oncogenic role if overexpressed, but not confirmed.

Dominant Negative (DN)

No evidence of dominant-negative effects.

Gene Ontology (GO)

• Molecular Function: protein binding (inferred from sequence similarity) • Biological Process: regulation of transcription
• DNA-templated (inferred from family members) • Cellular Component: nucleus (predicted)

Pathways

• No specific pathways curated for PRAMEF19; may be involved in immune response pathways via antigen presentation.

Protein Summary

The PRAMEF19 protein is a member of the PRAME family, characterized by the presence of PRAME domains. It is predicted to be a nuclear protein involved in transcriptional regulation. Its expression is primarily restricted to testis and placenta, and it is considered a cancer/testis antigen. The protein may play a role in inhibiting retinoic acid receptor signaling, similar to other PRAME family members, thereby affecting cell differentiation and proliferation. However, functional studies specific to PRAMEF19 are lacking.

Related Products

Product name Cat.No. Species Gene ID
PRAMEF19 Knockout HCT 116 Cell Line EDJ-KQ77411 Human 645414 Details Get a Quote
PRAMEF19 Knockout A-549 Cell Line EDJ-KQ69056 Human 645414 Details Get a Quote
PRAMEF19 Knockout HeLa Cell Line EDJ-KQ60586 Human 645414 Details Get a Quote
PRAMEF19 Knockout HEK293 Cell Line EDJ-KQ14881 Human 645414 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: